TerrAscend (TSNDF) Stock Price, News & Analysis

Company Overview

TerrAscend is a vertically integrated cannabis company that operates across cultivation, processing and retailing in North America. The company’s business model spans seed-to-sale activities, enabling it to manage quality control, production efficiency and product innovation from its growing facilities through to its distribution networks. TerrAscend serves both adult-use and medical cannabis markets, offering a full suite of cannabis derivatives including dried flower, concentrates, vapes, edibles, tinctures and topicals.

Geographically, TerrAscend maintains operations in key regulated markets. In the United States, the company holds cultivation and processing facilities in Pennsylvania, New Jersey and Rhode Island, along with state-licensed dispensaries serving patients and adult consumers. In Canada, TerrAscend is active in Ontario through its production site and partnerships that support wholesale distribution to provincial retail channels. This cross-border footprint positions the company to capture demand in both established and emerging markets.

Product development is driven by an in-house research and development team focused on consistent potency, lab-tested safety and branded consumer experiences. TerrAscend’s portfolio includes proprietary brands designed to appeal to a range of consumer segments, from wellness-oriented tinctures to high-thc extracts and pre-rolled formats. The company also offers wholesale flower and bulk extracts to licensed operators and third-party distributors under supply agreements.

Founded in 2018, TerrAscend trades on the Canadian Securities Exchange under the symbol TER and on the OTC markets as TSNDF. Under the leadership of Chief Executive Officer Jason Wild, the company prioritizes compliance, operational excellence and strategic market entry. TerrAscend’s management team leverages extensive industry and financial expertise to navigate evolving regulatory frameworks and pursue growth through organic expansion and targeted acquisitions.

Key Stats

• Today's Range: $0.47 to $0.52
• 50-Day Range: $0.47 to $0.77
• 52-Week Range: $0.35 to $1.45
• Volume: 136,891 shs
• Average Volume: 333,553 shs
• Market Capitalization: $158.18 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

TerrAscend Stock Analysis - MarketRank™

TerrAscend scored higher than 17% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.5 / 5
• Analyst Rating: Buy

Consensus Rating

TerrAscend has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

TerrAscend has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for TerrAscend are expected to grow in the coming year, from ($0.08) to ($0.06) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of TerrAscend is -5.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of TerrAscend is -5.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

TerrAscend has a P/B Ratio of 1.56. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.42% of the float of TerrAscend has been sold short.

Short Interest Ratio / Days to Cover

TerrAscend has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in TerrAscend has recently increased by 15.89%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

TerrAscend does not currently pay a dividend.

Dividend Growth

TerrAscend does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

MarketBeat Follows

2 people have added TerrAscend to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, TerrAscend insiders have not sold or bought any company stock.

Percentage Held by Insiders

31.86% of the stock of TerrAscend is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

5.83% of the stock of TerrAscend is held by institutions.

Company Calendar

• Last Earnings: 5/07/2026
• Today: 8/06/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:TSNDF
• Previous Symbol: OTC:TSNDF
• CIK: 1778129
• Web: www.terrascend.com
• Phone: 855-837-7295
• Fax: N/A
• Employees: 1,038
• Year Founded: 2017

Profitability

• EPS (Trailing Twelve Months): ($0.10)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$81.33 million
• Net Margins: -45.86%
• Pretax Margin: 2.15%
• Return on Equity: -24.69%
• Return on Assets: -4.46%

Debt

• Debt-to-Equity Ratio: 2.66
• Current Ratio: 1.51
• Quick Ratio: 0.98

Sales & Book Value

• Annual Sales: $260.56 million
• Price / Sales: 0.61
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.32 per share
• Price / Book: 1.60

Miscellaneous

• Outstanding Shares: 309,180,000
• Free Float: 210,673,000
• Market Cap: $158.18 million
• Optionable: Not Optionable
• Beta: 1.39